5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
J

Treatment Options for Newly Diagnosed Myeloma: Time to Incorporate CD38 Antibodies?

By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Jesus Berdeja
By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Jesus Berdeja
192 views
March 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
Hematologic Malignancies
06:39

Frontline Therapy in CLL: Obinutuzumab + Ibrutinib, Ibrutinib vs. Ch…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

I. Flinn

120 views
07:09

ELEVATE TN Data on Acalabrutinib - Practice Changing Trial in CLL

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

I. Flinn

228 views
11:47

Treatment Options for Newly Diagnosed Myeloma: Time to Incorporate C…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

J. Berdeja

192 views
09:00

Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among …

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

J. Berdeja

639 views
12:36

Future Directions in Multiple Myeloma: Selinexor Approval, Venetocla…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

J. Berdeja

60 views
18:23

Time Limited Therapy in CLL, Ibrutinib vs Zanubrutinib in WM & LOXO-…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

I. Flinn

77 views